dr. sharpless on managing toxicities with nivolumab/ipilimumab in melanoma
Published 8 years ago • 1K plays • Length 1:34Download video MP4
Download video MP3
Similar videos
-
1:57
dr. luke discusses the controversy surrounding ipilimumab/nivolumab combo in melanoma
-
2:10
dr. weber on the toxicity profile of nivolumab versus ipilimumab for melanoma
-
1:49
the significance of the ipilimumab/nivolumab findings in melanoma
-
1:30
dr. kluger on toxicity of nivolumab/ ipilimumab for advanced melanoma
-
1:00
dr. sznol on immune-related toxicities in melanoma
-
2:35
dr. atkins on long-term survival benefit of nivolumab/ipilimumab in advanced melanoma
-
3:24
ipilimumab side effect management in melanoma
-
5:39
nivolumab plus ipilimumab in advanced melanoma
-
14:27
melanoma patient story: immunotherapy treatment (nivolumab/opdivo) | rich’s story (5 of 5)
-
56:36
dr.shiva™ live: astragalus on hair loss @cytosolve systems analysis
-
4:00
cancer immunotherapy - pd-1 and pd-l1
-
1:01
dr. sznol on managing toxicities in treatment of melanoma
-
1:03
dr. long on nivolumab/ipilimumab in patients with melanoma brain metastases
-
1:17
dr. shoushtari on the role of nivolumab and ipilimumab in mucosal melanoma
-
1:38
dr. sosman on the mechanism of action of ipilimumab in melanoma
-
1:22
dr. sznol discusses the combination of ipilimumab and nivolumab in melanoma
-
1:15
dr. postow on nivolumab combined with ipilimumab in melanoma
-
1:02
dr. hodi on nivolumab in combination with ipilimumab for advanced melanoma
-
8:56
managing toxicity of immunotherapy in melanoma
-
1:38
dr. schadendorf on nivolumab/ ipilimumab combination trial in melanoma
-
3:16
optimizing the use of ipilimumab/nivolumab in mrcc
-
2:11
dr. long on rationale for nivolumab/ipilimumab in patients with melanoma who have brain mets